Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Quality of Life × 1 year × Clear all

Sponsor

Conditions

Neoplasms 3 Sarcoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Thymus Neoplasms 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Synovial 1 Peritoneal Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fatigue 1 Dermatofibrosarcoma 1 Cardiovascular Diseases 1 Carcinoma, Squamous Cell 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Paclitaxel 12 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 liposomal doxorubicin 5 Nivolumab 5 mirvetuximab soravtansine 4 Topotecan 4 ribociclib 3 olaparib 3 Fulvestrant 3 Drug Therapy 3 rucaparib 2 pegfilgrastim 2 palbociclib 2 oregovomab 2 niraparib 2 fludarabine phosphate 2 fludarabine 2 Irinotecan 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cyclophosphamide 2 Blood Specimen Collection 2 1-dodecylpyridoxal 2 trastuzumab deruxtecan 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 isoquercitrin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡